Japan
Showing 1 - 25 of 9,850
Lesion in Body Region, CNS Lesion Trial in Japan (Gadopiclenol, Comparator)
Recruiting
- Lesion in Body Region
- CNS Lesion
-
Aichi, Japan
- +27 more
Aug 28, 2023
SAPHNELO Systemic Lupus Erythematosus Japan Post-Marketing
Recruiting
- Lupus Erythematosus, Systemic
-
Aichi, Japan
- +93 more
Jan 24, 2023
Prostatic Tumors Trial in Japan (Androgen-deprivation Therapy (ADT), Bicalutamide, Abiraterone)
Active, not recruiting
- Prostatic Neoplasms
- Androgen-deprivation Therapy (ADT)
- +6 more
-
Akita, Japan
- +76 more
Jan 19, 2023
Tricuspid Valve Regurgitation, Heart Valve Diseases, Cardiovascular Diseases Trial in Japan (Edwards EWJ-202 Transcatheter
Recruiting
- Tricuspid Valve Regurgitation
- +2 more
- Edwards EWJ-202 Transcatheter Tricuspid Valve Replacement System
-
Kitakyushu-shi, Fukuoka, Japan
- +6 more
Feb 27, 2023
Long Term Post Marketing Specified Drug Use Result Survey for
Active, not recruiting
- Hypercholesterolemia
- Familial Hypercholesterolemia
- No intervention
-
Ichinomiya city, Aichi Prefecture, Japan
- +138 more
Dec 5, 2022
Ulcerative Colitis Trial in Japan (Etrasimod, Placebo)
Recruiting
- Ulcerative Colitis
- Etrasimod
- Placebo
-
Toyohashi-shi, Aichi- KEN, Japan
- +70 more
Jan 3, 2023
Hereditary Angioedema, HAE Trial in Japan (BCX7353 capsules, Placebo oral capsule)
Completed
- Hereditary Angioedema, HAE
- BCX7353 capsules
- Placebo oral capsule
-
Chiba, Japan
- +9 more
Jan 12, 2023
Periodontal Diseases, Chronic Periodontitis, Periodontal Pocket Trial in Japan (IQOS, Cigarette)
Completed
- Periodontal Diseases
- +5 more
- IQOS
- Cigarette
-
Futtsu, Chiba, Japan
- +25 more
Jan 26, 2023
Calquence CLL rr Japan PMS_Japan Post-Marketing Surveillance
Active, not recruiting
- Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
-
Aichi, Japan
- +48 more
Dec 7, 2022
Disease State in Adult Participants Being Treated With Humira in
Recruiting
- Pyoderma Gangrenosum
-
Nagoya shi, Aichi, Japan
- +44 more
Jan 13, 2023
Evusheld Japan PMS_Japan Post-Marketing Surveillance (PMS)
Recruiting
- SARS-CoV-2 Infection
-
Aichi, Japan
- +2 more
Jan 17, 2023
(PMS) for Underlying Disease at High-risk for Worsening COVID-19
Recruiting
- Prevention of Infectious Disease Caused by SARS-CoV-2
-
Akita, Japan
- +9 more
Feb 1, 2023
Gastroenteritis Trial in Japan (Placebo, HIL-214)
Recruiting
- Gastroenteritis
- Placebo
- HIL-214
-
Fukui-Shi, Japan
- +3 more
Aug 18, 2023
Migraine Trial in Japan (Atogepant, Placebo for Atogepant)
Not yet recruiting
- Migraine
- Atogepant
- Placebo for Atogepant
-
Ichikawa-shi, Chiba, Japan
- +49 more
May 8, 2023
Chronic Coronary Syndrome, Non ST Segment Elevation Acute Coronary Syndrome Trial in Ireland, Japan (prasugrel Monotherapy)
Recruiting
- Chronic Coronary Syndrome
- Non ST Segment Elevation Acute Coronary Syndrome
- prasugrel Monotherapy
-
Galway, Ireland
- +12 more
Nov 1, 2022
Relapsed or Refractory T-cell Lymphomas Trial in Sendai-shi (BMS-986369)
Not yet recruiting
- Relapsed or Refractory T-cell Lymphomas
-
Sendai-shi, Miyagi, JapanLocal Institution - 0001
Sep 12, 2023
Prostate Cancer Trial in Sapporo city, Kanazawa-city (177Lu-PSMA-617, 68Ga-PSMA-11, Best supportive/best standard of care)
Recruiting
- Prostate Cancer
- 177Lu-PSMA-617
- +2 more
-
Kashiwa, Chiba, Japan
- +6 more
Jan 23, 2023
Assess Frequency Of Serious Infections In Clinical Practice In
Recruiting
- Rheumatoid Arthritis (RA)
-
Gamagori, Aichi, Japan
- +893 more
Jan 24, 2023
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in Japan (Venetoclax, Ibrutinib, Obinutuzumab)
Recruiting
- Chronic Lymphocytic Leukemia (CLL)
- Small Lymphocytic Lymphoma (SLL)
- Venetoclax
- +2 more
-
Nagoya-shi, Aichi, Japan
- +19 more
Jan 25, 2023
Disease Activity and Adverse Events in Adolescent and Adult
Recruiting
- Crohn's Disease
-
Toyota-shi, Aichi, Japan
- +1 more
Aug 29, 2023
Adverse Events and Change in Disease Activity in Participants of
Recruiting
- Acute Myeloid Leukemia (AML)
-
Anjo-shi, Aichi, Japan
- +233 more
Jan 12, 2023
Disease Activity and Adverse Events of RINVOQ in Adult
Recruiting
- Ankylosing Spondylitis
-
Kasugashi, Aichi, Japan
- +22 more
Jan 24, 2023
Overall Survival in Japanese HR+/HER2- Advanced Breast Cancer
Active, not recruiting
- Breast Cancer
- palbociclib plus letrozole
-
Chiba-shi, Chiba, Japan
- +12 more
Dec 15, 2022
Maviret in Adolescent Chronic Hepatitis C Virus
Recruiting
- Hepatitis C Virus (HCV)
-
Kariya-shi, Aichi, Japan
- +34 more
Oct 27, 2022